Edwards Lifesciences Corp... (EW)
NYSE: EW
· Real-Time Price · USD
78.31
0.13 (0.17%)
At close: Aug 15, 2025, 2:46 PM
Edwards Lifesciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.27B | 3.14B | 3.05B | 3.68B | 1.64B | 1.22B | 1.13B | 1.41B | 1.04B | 872.5M | 769M | 1.25B | 1.2B | 1.03B | 862.8M | 1.51B | 1.31B | 1.17B |
Short-Term Investments | n/a | 757.9M | 930.7M | 769.7M | 345.3M | 473M | 500.5M | 453.8M | 466.7M | 381.7M | 446.3M | 490.9M | 317.7M | 465M | 604M | 287.8M | 248.4M | 156.4M |
Long-Term Investments | 298.5M | 277.9M | 307.9M | 319.6M | 353.3M | 455.6M | 583.9M | 704.6M | 856.2M | 1.07B | 1.24B | 1.38B | 1.49B | 1.62B | 1.83B | 1.28B | 1.01B | 802.2M |
Other Long-Term Assets | 755.8M | 755.1M | 732.4M | 694M | 1.1B | 767.6M | 774.3M | 447.4M | 412.1M | 293.6M | 299.1M | 316.5M | 234.7M | 129.4M | 110.8M | 133.7M | 105.3M | 125.5M |
Receivables | 902.6M | 751.9M | 727.4M | 811.5M | 834.4M | 876.9M | 828.1M | 802.1M | 816.9M | 779.3M | 699.1M | 661.4M | 679.2M | 686.2M | 664.9M | 664.2M | 700.3M | 664.3M |
Inventory | 1.14B | 1.11B | 1.09B | 1.1B | 1.02B | 1.21B | 903.5M | 1.03B | 980.2M | 914.3M | 875.5M | 757.8M | 740M | 730.6M | 726.7M | 737.8M | 759.5M | 767.9M |
Other Current Assets | 1.26B | 337.1M | 374.4M | 251M | 556.9M | 250.6M | 542.5M | 235.8M | 217.4M | 190.3M | 195.9M | 267.6M | 248.8M | 234.5M | 237.1M | 241.9M | 233.3M | 229.1M |
Total Current Assets | 6.58B | 6.21B | 6.29B | 6.73B | 4.52B | 4.17B | 4.04B | 4.07B | 3.65B | 3.26B | 3.1B | 3.51B | 3.26B | 3.24B | 3.18B | 3.52B | 3.32B | 3.07B |
Property-Plant & Equipment | 1.83B | 1.8B | 1.78B | 1.78B | 1.73B | 1.87B | 1.68B | 1.77B | 1.75B | 1.73B | 1.73B | 1.65B | 1.64B | 1.64B | 1.64B | 1.55B | 1.53B | 1.51B |
Goodwill & Intangibles | 2.95B | 2.95B | 2.95B | 2.56B | 1.57B | 1.7B | 1.54B | 1.73B | 1.73B | 1.76B | 1.45B | 1.43B | 1.48B | 1.49B | 1.49B | 1.5B | 1.5B | 1.5B |
Total Long-Term Assets | 6.91B | 6.81B | 6.77B | 6.24B | 5.58B | 5.57B | 5.33B | 5.3B | 5.36B | 5.39B | 5.2B | 5.12B | 5.16B | 5.18B | 5.32B | 4.64B | 4.34B | 4.14B |
Total Assets | 13.49B | 13.02B | 13.06B | 12.97B | 10.1B | 9.74B | 9.36B | 9.37B | 9B | 8.65B | 8.29B | 8.64B | 8.43B | 8.42B | 8.5B | 8.16B | 7.66B | 7.21B |
Account Payables | 162.1M | 172.4M | 197.4M | 172.8M | 185.9M | 212.3M | 186.6M | 190.6M | 193M | 180.8M | 201.9M | 154.9M | 162.5M | 158.8M | 204.5M | 139.5M | 144.6M | 150.4M |
Deferred Revenue | n/a | 46.2M | 53.7M | 66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 25.9M | 23.7M | 23.4M | 24.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.38B | 375.4M | 419.3M | 353.6M | 409.5M | 252.3M | 530.2M | 360.5M | 344.9M | 264M | 305M | 270.6M | 271.2M | 244.9M | 342.7M | 328.5M | 287.9M | 228.4M |
Total Current Liabilities | 1.4B | 1.39B | 1.51B | 1.94B | 1.22B | 1.11B | 1.2B | 1.24B | 1.16B | 1.08B | 1.02B | 917.9M | 969.1M | 949.9M | 1.03B | 966.5M | 886.2M | 799M |
Long-Term Debt | 676.7M | 597.8M | 597.7M | 597.5M | 597.3M | 597.2M | 597M | 596.8M | 596.7M | 596.5M | 596.3M | 596.2M | 596M | 595.9M | 595.7M | 595.5M | 595.4M | 595.2M |
Other Long-Term Liabilities | 800.8M | 760.2M | 810.6M | 733.2M | 706.2M | 764.7M | 786.2M | 738M | 740.1M | 844.5M | 797.6M | 839.2M | 852.9M | 960.8M | 969.6M | 992.6M | 983.5M | 1.09B |
Total Long-Term Liabilities | 1.48B | 1.44B | 1.49B | 1.42B | 1.38B | 1.44B | 1.45B | 1.4B | 1.4B | 1.51B | 1.46B | 1.5B | 1.51B | 1.63B | 1.63B | 1.65B | 1.64B | 1.76B |
Total Liabilities | 2.88B | 2.83B | 2.99B | 3.36B | 2.59B | 2.55B | 2.64B | 2.64B | 2.56B | 2.59B | 2.49B | 2.42B | 2.48B | 2.58B | 2.67B | 2.62B | 2.53B | 2.56B |
Total Debt | 702.6M | 699.4M | 700M | 706.7M | 693M | 699.2M | 685.1M | 691.1M | 684.5M | 687.8M | 691.3M | 686.8M | 682.8M | 688.2M | 690.3M | 684.1M | 684.2M | 688.8M |
Common Stock | 657.6M | 655.9M | 654.8M | 654.3M | 653.5M | 651.8M | 650.5M | 649.9M | 649.1M | 647.1M | 646.3M | 645.7M | 645M | 642.9M | 642M | 641.2M | 640.1M | 637.5M |
Retained Earnings | 13.86B | 13.53B | 13.17B | 12.78B | 9.71B | 9.34B | 8.99B | 8.62B | 8.24B | 7.93B | 7.59B | 7.19B | 6.85B | 6.44B | 6.07B | 5.73B | 5.39B | 4.9B |
Comprehensive Income | -264.1M | -254.5M | -244.5M | -252.5M | -220.2M | -233.3M | -242.8M | -250.1M | -255.5M | -255.4M | -254.9M | -256M | -224.4M | -186.6M | -157.7M | -155.4M | -159.6M | -172.4M |
Shareholders Equity | 10.55B | 10.13B | 10B | 9.55B | 7.44B | 7.12B | 6.65B | 6.66B | 6.38B | 5.98B | 5.81B | 6.22B | 5.94B | 5.84B | 5.84B | 5.54B | 5.13B | 4.66B |
Total Investments | n/a | 1.04B | 1.24B | 1.09B | 698.6M | 928.6M | 1.08B | 1.16B | 1.32B | 1.45B | 1.69B | 1.87B | 1.81B | 2.09B | 2.44B | 1.57B | 1.26B | 958.6M |